Literature DB >> 25988210

Comments on Liu Yet al. "Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies".

Fanxiao Liu, Qingyu Zhang, Jianmin Li, Zhenfeng Li, Honglei Jia, Dongsheng Zhou.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25988210     DOI： 10.1007/s13277-015-3303-8

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  9 in total

1.  Loss of ErbB2 expression in pulmonary metastatic lesions in osteosarcoma.

Authors:  T Akatsuka; T Wada; Y Kokai; N Sawada; S Yamawaki; S Ishii
Journal:  Oncology       Date:  2001       Impact factor: 2.935

2.  Clinicopathologic analysis of HER-2/neu immunoexpression among various histologic subtypes and grades of osteosarcoma.

Authors:  S E Kilpatrick; K R Geisinger; T S King; J Sciarrotta; W G Ward; S H Gold; G D Bos
Journal:  Mod Pathol       Date:  2001-12       Impact factor: 7.842

3.  Expression of HER2/erbB-2 correlates with survival in osteosarcoma.

Authors:  R Gorlick; A G Huvos; G Heller; A Aledo; G P Beardsley; J H Healey; P A Meyers
Journal:  J Clin Oncol       Date:  1999-09       Impact factor: 44.544

4.  ErbB2 expression is correlated with increased survival of patients with osteosarcoma.

Authors:  Tomohiro Akatsuka; Takuro Wada; Yasuo Kokai; Satoshi Kawaguchi; Kazuo Isu; Katsushige Yamashiro; Toshihiko Yamashita; Norimasa Sawada; Shinya Yamawaki; Seiichi Ishii
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

5.  C-erbB-2 expression and prognostic significance in osteosarcoma.

Authors:  Bilgehan Yalçin; Gökhan Gedikoğlu; Tezer Kutluk; Ali Varan; Canan Akyüz; Münevver Büyükpamukçu
Journal:  Pediatr Blood Cancer       Date:  2008-08       Impact factor: 3.167

6.  Her-2/neu expression in osteosarcoma increases risk of lung metastasis and can be associated with gene amplification.

Authors:  Holly Zhou; R Lor Randall; Arthur R Brothman; Teresa Maxwell; Cheryl M Coffin; Robert E Goldsby
Journal:  J Pediatr Hematol Oncol       Date:  2003-01       Impact factor: 1.289

7.  Effect of c-erbB2 overexpression on prognosis in osteosarcoma: evidence from eight studies.

Authors:  Yu Liu; Yun-Hong Ma; Zhen-Zhong Sun; Yong-Jun Rui; Qu-Dong Yin; Sheng Song; Xu-Ming Wei; Jun Liu; Xue-Guang Liu; Ke-Jia Hu
Journal:  Tumour Biol       Date:  2014-06-05

8.  ErbB-2 expression is correlated with poor prognosis for patients with osteosarcoma.

Authors:  M Onda; S Matsuda; S Higaki; T Iijima; J Fukushima; A Yokokura; T Kojima; H Horiuchi; T Kurokawa; T Yamamoto
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

9.  Immunohistochemical expression of vegf and her-2 proteins in osteosarcoma biopsies.

Authors:  Ricardo Gehrke Becker; Carlos Roberto Galia; Sandra Morini; Cristiano Ribeiro Viana
Journal:  Acta Ortop Bras       Date:  2013-07       Impact factor: 0.513
  9 in total
  1 in total

Review 1.  HER-2 expression in biopsy and surgical specimen on prognosis of osteosarcoma: A systematic review and meta-analysis of 16 studies.

Authors:  Qingyu Zhang; Fanxiao Liu; Bomin Wang; Zhenfeng Li; Dongsheng Zhou; Qiang Yang; Jinlei Dong; Jianmin Li
Journal:  Medicine (Baltimore)       Date:  2016-06       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.